- The Efficacy of Short-term Administration of Revaprazan on Gastroesophageal Reflux Symptoms: Comparison with Half Dose Esomeprazole, a Pilot Study
-
Lee HM, Kim BW, Kim JS, Im EJ, Kim JI, Kang BK, Ji JS, Lee BI, Choi H
- KMID: 2305175
- Korean J Helicobacter Up Gastrointest Res.
- 2012 Mar;12(1):23-26.
- doi: 10.7704/kjhugr.2012.12.1.23
BACKGROUND/AIMS: Revaprazan, an acid pump antagonist, is a kind of gastric acid suppressant and is prescribed for the treatment of peptic ulcers and gastritis. However, the efficacy of revaprazan on... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Acid Pump Antagonist (Revaprazan, Revanex(R)) on the Result of 13C Urea Breath Test in the Patients with Helicobacter pylori Associated Peptic Ulcer Disease
-
Park SY
- KMID: 991460
- Korean J Gastroenterol.
- 2011 Jan;57(1):1-2.
- doi: 10.4166/kjg.2011.57.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Voiding Parameters According to the Subtypes of SS-Penogram in Patients with Both Erectile Dysfunction and Lower Urinary Symptoms
-
Choi HM, Choi HK, Kim CE, Chung BH
- KMID: 2298784
- Korean J Androl.
- 2009 Aug;27(2):89-95.
PURPOSE: We investigated the results of voiding parameters according to the subtypes of audiovisual stimulation (AVS)- and sexual stimulation (SS)-penogram in patients with both erectile dysfunction (ED) and lower urinary... -
- CITED
-
- Close
- SHARE
-
- Close
- A Matched Case-Control Study of a Novel Acid-Pump Antagonist and Proton-Pump Inhibitor for the Treatment of Iatrogenic Ulcers Caused by Endoscopic Submucosal Dissection
-
Kim YG, Jang BI, Kim TN
- KMID: 2167202
- Gut Liver.
- 2010 Mar;4(1):25-30.
BACKGROUND/AIMS: Revaprazan, a novel acid-pump antagonist, and proton-pump inhibitors (PPIs) have pH-independent effects on ulcer healing. The addition of a PPI promotes the cell restitution rate as well as vessel... -
- CITED
-
- Close
- SHARE
-
- Close
- The Analysis of Clinical Efficacy of Phosphodiesterase 5 Inhibitors for Erectile Dysfunction using SS-Penogram
-
Choi KH, Soh BH, Oh CY, Kim JH, Choi HK
- KMID: 2298730
- Korean J Androl.
- 2009 Dec;27(3):194-200.
PURPOSE: As the first-line pharmacotherapy for erectile dysfunction (ED), phosphodiesterase type 5 (PDE5) inhibitors are widely used and their clinical efficacy is well established. But up to now, most of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Mirodenafil, a Phosphodiesterase-5 Inhibitor, on Female Rat Bladder in a Partial Bladder Outlet Obstruction Model: Physiological and Immunohistochemical Aspects
-
Kang JY, Kim EK, Kim KM
- KMID: 2061517
- Korean J Urol.
- 2013 May;54(5):339-344.
- doi: 10.4111/kju.2013.54.5.339
PURPOSE: We investigated the effects of mirodenafil, a phosphodiesterase-5 inhibitor developed in South Korea, on the female rat bladder in a partial bladder outlet obstruction (BOO) model. MATERIALS AND METHODS: Thirty-six... -
- CITED
-
- Close
- SHARE
-
- Close
- A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study
-
Jo Y, Park E, Ahn SB, Jo YK, Son B, Kim SH, Park YS, Kim HJ
- KMID: 2234066
- Gut Liver.
- 2015 Sep;9(5):607-614.
- doi: 10.5009/gnl14135
BACKGROUND/AIMS: Proton pump inhibitors (PPIs) act by irreversibly binding to the H+-K+-ATPase of the proton pump in parietal cells and may possibly affect the vacuolar H+-ATPase in osteoclasts. METHODS: We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B
-
Cho YK, Song BC
- KMID: 1128352
- Korean J Gastroenterol.
- 2011 Mar;57(3):144-149.
- doi: 10.4166/kjg.2011.57.3.144
Over the past decade, advances in the antiviral therapy in patients with chronic hepatitis B have enabled the sustained suppression of hepatitis B viral replication and the prevention of progressive... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Multidrug-Resistant Human Immunodeficiency Virus Infection Treated with Atazanavir and Lopinavir/Ritonavir Combination Therapy
-
Choi H, Jeong SJ, Lee HS, Chin BS, Choi SH, Han SH, Kim MS, Kim CO, Choi JY, Song YG, Kim JM
- KMID: 1785841
- J Korean Med Sci.
- 2008 Aug;23(4):737-739.
- doi: 10.3346/jkms.2008.23.4.737
The combination of atazanavir (ATV) and lopinavir/ritonavir (LPV/RTV) with nucleoside reverse transcriptase inhibitors (NRTI) has been used as a salvage regimen for human immunodeficiency virus (HIV)-positive patients. In this paper,... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Antiviral-Resistant Chronic Hepatitis B Virus Infection
-
Yim HJ
- KMID: 1767539
- Korean J Gastroenterol.
- 2008 Jun;51(6):346-359.
Substantial progress has been made in the treatment of chronic hepatitis B during the past decade. Nucleos(t)ide analogues are now widely used due to their convenience, less side effects, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Acid Pump Antagonist (Revaprazan, Revanex(R)) on Result of 13C Urea Breath Test in Patients with Helicobacter pylori Associated Peptic Ulcer Disease
-
Oak JH, Chung WC, Jung SH, Choi KH, Kim EJ, Kang BK, Kang B, Kong SE, Paik CN, Lee KM
- KMID: 991462
- Korean J Gastroenterol.
- 2011 Jan;57(1):8-13.
- doi: 10.4166/kjg.2011.57.1.8
BACKGROUND/AIMS: Revaprazan (Revanex(R)) is a novel proton pump inhibitor (PPI) that has a somewhat different effect on proton pump compared with the other PPI's, also (called as 'acid pump antagonist').... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B
-
Moon YM, Hwang SG, Kim BS, Rim KS, Cho M, Kim DJ, Han JY, Kim YS, Choi HS, Ahn SH
- KMID: 1776826
- Korean J Hepatol.
- 2007 Dec;13(4):503-512.
- doi: 10.3350/kjhep.2007.13.4.503
BACKGROUND AND AIMS: Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine is more potent than lamivudine for... -
- CITED
-
- Close
- SHARE
-
- Close
